EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieOpen Access

Lactated Ringer vs Normal Saline Solution During Sickle Cell Vaso-Occlusive Episodes

Augusta K Alwang, Anica C Law, Elizabeth S Klings, Robyn T Cohen, Nicholas A Bosch

JAMA Internal Medicine · 2024

DOI: 10.1001/jamainternmed.2024.4428 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA Internal Medicine, 2024. Verfasst von Augusta K Alwang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Ringer's Lactate, Saline Solution, Fluid Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Sickle cell disease (SCD), a clinically heterogenous genetic hemoglobinopathy, is characterized by painful vaso-occlusive episodes (VOEs) that can require hospitalization. Patients admitted with VOEs are often initially resuscitated with normal saline (NS) to improve concurrent hypovolemia, despite preclinical evidence that NS may promote erythrocyte sickling. The comparative effectiveness of alternative volume-expanding fluids (eg, lactated Ringer [LR]) for resuscitation during VOEs is unclear.

Objective

To compare the effectiveness of LR to NS fluid resuscitation in patients with SCD and VOEs. Design, Setting, and Participants This multicenter cohort study and target trial emulation included inpatient adults with SCD VOEs who received either LR or NS on hospital day 1. The Premier PINC AI database (2016-2022), a multicenter clinical database including approximately 25% of US hospitalizations was used. The analysis took place between October 6, 2023, and June 20, 2024. Exposure Receipt of LR (intervention) or NS (control) on hospital day 1. Main Outcome and Measures The primary outcome was hospital-free days (HFDs) by day 30. Targeted maximum likelihood estimation was used to calculate marginal effect estimates. Heterogeneity of treatment effect was explored in subgroups.

Results

A total of 55 574 patient encounters where LR (n = 3495) or NS (n = 52 079) was administered on hospital day 1 were included; the median (IQR) age was 30 (25-37) years. Patients who received LR had more HFDs compared with those who received NS (marginal mean difference, 0.4; 95% CI, 0.1-0.6 days). Patients who received LR also had shorter hospital lengths of stay (marginal mean difference, −0.4; 95% CI, −0.7 to −0.1 days) and lower risk of 30-day readmission (marginal risk difference, −5.8%; 95% CI, −9.8% to −1.8%). Differences in HFDs between LR and NS were heterogenous based on fluid volume received: among patients who received less than 2 L, there was no difference in LR vs NS; among those who received 2 or more L, LR was superior to NS. Conclusion and Relevance This cohort study found that, compared with NS, LR had a small but significant improvement in HFDs and secondary outcomes including 30-day readmission. These results suggest that, among patients with VOEs in whom clinicians plan to give volume resuscitation fluids on hospital admission, LR should be preferred over NS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellRinger's LactateSaline SolutionFluid TherapyHumansMaleFemaleAdultResuscitationMiddle AgedTreatment Outcome

Substanzen

Ringer's LactateSaline Solution

Autor:innen und Institutionen

  • Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
  • The Pulmonary Center, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
  • The Center of Excellence in Sickle Cell Disease, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
  • Pediatic Pulmonary & Allergy, Department of Pediatrics, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
  • Evans Center for Implementation and Improvement Sciences, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.

Zitieren

APA

Alwang, A. K., Law, A. C., Klings, E. S., Cohen, R. T., & Bosch, N. A. (2024). Lactated Ringer vs Normal Saline Solution During Sickle Cell Vaso-Occlusive Episodes. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2024.4428

Vancouver

Alwang AK, Law AC, Klings ES, Cohen RT, Bosch NA. Lactated Ringer vs Normal Saline Solution During Sickle Cell Vaso-Occlusive Episodes. JAMA Internal Medicine. 2024. doi:10.1001/jamainternmed.2024.4428

BibTeX
@article{Alwang2024,
  author = {Alwang, Augusta K and Law, Anica C and Klings, Elizabeth S and Cohen, Robyn T and Bosch, Nicholas A},
  title = {Lactated Ringer vs Normal Saline Solution During Sickle Cell Vaso-Occlusive Episodes},
  journal = {JAMA Internal Medicine},
  year = {2024},
  doi = {10.1001/jamainternmed.2024.4428}
}
Kostenlos starten →